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ABSTRACT: 
Protein misfolding and aggregation results in many human diseases and some diseases are 
caused when protein aggregation leads to amyloid formation (Chiti and Dobson, 2006). 
Amyloids are rigid, insoluble, unbranched, fibrous and well organized proteinaceous materials 
having cross-β core structure (Chiti and Dobson, 2006) (Nelson et al., 2005). They have 
characteristic “cross β-sheet” structure, revealed by X-ray diffraction studies. Detection of 
amyloid can be done by both congo red binding and thioflavin-T (Th-T) assay.Thermodynamic 
properties of complexes of Congo Red (CR) dye with amyloid β (Aβ) peptides were studied by 
absorption spectroscopy and thioflavin-T were studied by fluorescence spectroscopy. Inhibition 
of pathogenic protein aggregation may be an important and straight forward therapeutic strategy 
for curing amyloid diseases.inhibitory effect of 3-aminophenol , GPS-1, GPS-2 on bovine serum 
albumin , lysozyme, rnq1 prion protein amyloid aggregates were studied. 3 aminophenol shows 
significant inhibitory action on lysozyme amyloid aggregates. 
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 1. INTRODUCTION: 
1.1 AMYLOID AGGREGATION: 
Peptides or proteins convert under some conditions from their soluble forms into highly ordered 
fibrillar aggregates. Such transitions can give rise to pathological conditions . these pathological 
conditions are generally referred to as protein misfolding desease(Chiti and Dobson, 2006). Some 
of these diseases are caused due to protein aggregation in an amyloid fashion. Amyloids are 
unbranched, fibrillar, rigid, insoluble, highly organized and protease-resistant aggregates of 
proteins(Chiti and Dobson, 2006) (Nelson et al., 2005).. These are approximately 75-100 Å in 
diameter. They have characteristic “cross β-sheet” structure, revealed by X-ray diffraction 
studies.  
                                            
Figure 1: Typical morphology of amyloid fibrils observed under electron microscope 
(Sunde and Blake, 1997). 
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Figure 2:  Cross beta structure present in amyloids (Nelson et al., 2005). 
Amyloids differ from other fibrillar structures like collagen or silk fibroin in their ability to 
bind the dye Congo red and exhibit bright apple green birefringence when viewed under 
polarized light, and the dye Thioflavin T exhibiting bright fluorescence (LeVine, 1993). 
Amyloid aggregates are partially stable against protease (proteinase K) and detergents like SDS 
and sodium lauroyl sarcosinate at room temperature. 
                         
Figure 3: (a) Red in Bright field microscopy (b) Bright apple green birefringence in Polarized 
light microscopy (Merlini and Bellotti, 2003). 
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 figure 4: Characteristic increase in ThT fluorescence upon binding to amyloid fibrils. 
 
Amyloid formation is a nucleation dependent process.  The rate of growth of amyloid 
fibres is increased by the presence of pre-formed aggregates i.e. seed. This process is known as 
seeding. 
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Figure 5: (A) Schematic of Amyloid aggregation. (B) Amyloid formation by nucleation 
dependent polymerization mechanism (Sunde and Blake, 1997). 
 
1.2 AMYLOIDOSIS: 
Amyloidosis is the pathological state associated with the deposition of conformationally altered 
proteins in the amyloid state, generally in the extracellular spaces of organs or tissues (called 
plaques or amyloid fibrils) or sometimes as intracellular “inclusions bodies”. The most well 
known neurodegenerative disease caused due to amyloid deposits is the Alzheimer’s disease 
caused by the deposition of Aβ 1-40 peptide fragments. Parkinson’s and Huntington’s diseases 
are caused by the aggregation of α-synuclein and huntingtin protein, respectively, however they 
lack amyloid characteristics. 
Amyloid deposition can be systemic or localized. When the amyloid is restricted to a 
particular organ or tissue, it is called localized amyloidosis. Organs generally affected by 
amyloid depositions are the kidneys, spleen, cardiac muscles and brain. Example- Injection-
localized amyloidosis due to repeated insulin injections occurs in the kidneys and the muscles. 
When the depositions are found in  any  or  all  of  the  body  regions,  in  the  blood  and  blood  
vessel  walls,  it  is  called  systemic amyloidosis.  Example-  immunoglobin  light  chain  
amyloidosis  (AL  amyloidosis)  occurs  in  most tissues. 
 
1.3 AMYLOID DETECTION: 
Detection of amyloid can be done by both congo red binding and thioflavin-T (Th-T) 
assay.Thermodynamic properties of complexes of Congo Red (CR) dye with amyloid β (Aβ) 
peptides were studied by  absorption spectroscopy and thioflavin-T were studied by fluorescence 
spectroscopy.  This fibrillar material possesses extensive β-sheet structure as revealed by far-UV 
CD and IR spectroscopy. Furthermore, the fibrils exhibit Congo red birefringence, increased 
fluorescence with thioflavine T and cause a red-shift of the Congo red absorption spectrum. All 
of these characteristics are typical of amyloid fibrils. The results indicate that formation of 
amyloid occurs when the native fold of a protein is destabilized under conditions in which 
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noncovalent interactions, and in particular hydrogen bonding, within the polypeptide chain 
remain favorable.  
 
1.4  FUNCTIONAL AMYLOID AGGREGATES: 
 
Formation of amyloid structure is an inherent or generic property of polypeptide chains . 
Amyloids are not only cytotoxic but amyloid like structures are also present naturally which do 
not cause diseases, are called “functional amyloids”  having a beneficial role, for example 
E.coli have a protein called curlin which forms amyloid structures and helps the organism to 
colonize on inert surfaces and mediate binding to host proteins. The fungus Neurospora crassa  
secrete hydrophobins  which  are  amyloid  forming  proteins  that  lower  the  water  surface  
tension  and  allow  the development of aerial hyphae. 
Other functional amyloids include chaplins (Streptomyces coelicolor), hydrophobin EAS 
(Neurospora crassa), proteins of chorion of the eggshell (Bombyx mori), intralumenal domain 
of Pmel17 (Homo sapiens), Ure2p (Saccharomyces cerevisiae), Sup35p (Saccharomyces 
cerevisiae), Rnq1p (Saccharomyces  cerevisiae),  HET-s  (Podospora  anserina)  and  neuron-
specific  isoform  of  CPBE (Aplisia californica) (Chiti and Dobson, 2006). 
 
1.5 Amyloid aggregate forming proteins: 
Amyloid formation is an intrinsic property of most proteins not just of those involved in 
disease states. The SH3 domain found in many proteins involved in the rapid formation of 
amyloid fibrils. It is 60–85 amino acid long and forms a compact β-barrel motif. 
 
Amyloid aggregate forming proteins either associated with diseases for e.g. Huntingtin, 
Alpha- synuclein, Aβ peptide and Lysozyme etc or no association with diseases for e.g. 
BSA, HSA, Sup35 and Curlin etc. Non-disease amyloid forming proteins are used as a model 
system to understand: General mechanism of formation of amyloid (Bhattacharya et al., 
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2011); cross-seeding e.g. study of crossing of species barrier by : (a) sup35 prion protein 
between S. cerevisiae and C. albicans (Vishveshwara and Liebman, 2009). (b) cow prions are 
infectious to humans causing vCJD disease (Zou and Gambetti, 2009); potential application 
as structural nano-materials (Cherny and Gazit, 
2008);  to  understand  the propagation  of amyloid and prion e.g. sup  35  is used to study 
th e infection mechanism of prion (Tanaka et al., 2005) and any other applications e.g. drug 
delivery agent. Insulin amyloid aggregates can be used for diabetes treatment (Gupta et al., 
2010). 
 
1.6 Bovine serum albumin: 
BSA is  a  serum  albumin  found  in  a  biological  subfamily  Bovinae  (domestic  cattle, 
African buffalo, the water buffalo, the yak, and the four-horned antelopes etc). This protein is  
acidic, all alpha, highly soluble, multi-domain and characterized  by high structural stability. 
Molecular weight of BSA is 66 KD. BSA is  the  single  peptide  chain  of  583  amino  acids. 
The secondary structure of BSA  molecule is composed of 67% a l p h a -helix, no  beta-sheet, 
10% turn, and 23% extended chain.  
 
1.7  INHIBITORS: 
Inhibition of pathogenic protein aggregation may be an important and straight forward 
therapeutic strategy for curing amyloid diseases. Numerous phenolic compounds have been 
reported to have an inhibitory role on amyloid formation of proteins. No inhibitor known for 
[psi+] 
s.no. Name of the 
compound 
Structure 
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2 MATERIALS AND METHODS: 
2.1 MATERIALS: 
bovine serum albumin (BSA),lysozyme,3-aminophenol,GPS-1,Congo red (CR), Thioflavin T 
(ThT), sodium salt, PBS(Ph-7.4), p1510 , 10mM Hcl, SDS, distilled water , Ni-NTA 
2.2METHODS 
2.2.1 PREPERATION OF BSA PROTEIN AND LYSOZYME AMYLOID 
AGGREGATES: 
BSA and 50mM NaCl were  dissolved in sodium phosphate buffer, pH 7.4 to a final 
concentration of 10-20 mg/ml and incubated at 65°C in a water bath for 6 hrs and 10 hrs 
respectively without agitation. 
 Incubate 10 mg/ml lysozyme in 10 mM HCl solution (pH 2.0) at 65 °C in a water bath for 24 
hrs.  
16 
 
The growth of amyloid fibrils was monitored and characterized by ThT fluorescence and 
transmission electron microscopy. 
 
2.2.2 AMYLOID CONFIRMATORY ASSAYS: 
2.2.2(A) Congo red dye binding assay 
 BSA was dissolved with Congo red dye in phosphate buffered saline, pH 7.4 in 1:1 ratio and the 
mixture was incubated for 30 min at RT. The absorbance spectrum was measured from 
250nm to 700nm in Molecular Devices M5e Spectra Max Multimode microplate reader (Holm et 
al., 2007) (Hawe et al., 2008). 
 
 
2.2.2(B) Thioflavin T dye binding assay 
45µl BSA aggregate sample was mixed with 5µl ThT of 30 mM stock. Fluorescence was 
measured in a Molecular Devices M5e Spectra Max Multimode microplate reader with excitation 
and emission wavelengths of 450 and 485nm, respectively for endpoint reading. Excitation 
spectrum was measured by scanning the excitation wavelength from 250 nm to 470 nm and 
detecting emission at 495 nm. For emission spectrum, excitation wavelength is 442nm and 
scanned emission wavelength from 460nm to 560nm(LeVine, 1993). 
 
 
2.3 INHIBITORY ASSAY: 
To study inhibitory effect on BSA amyloid fibrillization triplicates of following samples were 
taken.  1) BSA aggregate sample with inhibitor        2) BSA aggregate sample without inhibitor                                                            
 3)blank with inhibitor                                    4)blank without inhibitor   
And add 5µl ThT of 30 mM stock mix with water to makeup volume. Fluorescence was 
measured in a Molecular Devices M5e Spectra Max Multimode microplate reader 
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2.4   procedure to find the inhibitor for p1510 rnq1 protein 
 
 
             
 
       
 
 
 
 
 
 
 
 
                 
                     
2.4.1. ISOLATION OF P1510 (Rnq+ prion domain): 
Alkaline lysis is a method used in molecular biology , to isolate plasmid DNA or other cell 
components such as proteins by breaking the cells open. Bacteria containing the plasmid of 
interest is first grown, and then allowed to lyse with an alkaline lysis buffer consisting of a 
detergent sodium dodecyl sulfate (SDS) and a strong base sodium hydroxide. The detergent 
                                  SDS PAGE 
                               EXPRESSION 
                           PURIFICATION 
                  ISOLATION OF P1510 
       TRANSFORMATION INTO  BL21AI CELLS 
               AMYLOID AGGREGATION STUDY 
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cleaves the phospholipid bilayer of  membrane and the alkali denatures the proteins which are 
involved in maintaining the structure of the cell membrane. Through a series of steps involving 
agitation, precipitation, centrifugation, and the removal of supernatant, cellular debris is removed 
and the plasmid is isolated and purified. 
procedure: 
1. Resuspend pelleted bacterial cells in 250 µl Buffer P1 and transfer to a microcentrifuge tube. 
2. Add 250 µl Buffer P2 and gently invert the tube 4–6 times to mix. 
3. Add 350 µl Buffer N3 and invert the tube immediately but gently 4–6 times. 
4. Centrifuge for 10 min at 13,000 rpm  in  microcentrifuge. 
5. Apply the supernatants  to the QIAprep Spin Column by decanting or pipetting. 
6. Centrifuge for 30–60 s. Discard the flow-through.  
7. Wash the QIAprep Spin Column by adding 0.5 ml Buffer PB and centrifuging for 30–60 s.   
    Discard the flow-through. 
8. Wash QIAprep Spin Column by adding 0.75 ml Buffer PE and centrifuging for 30–60 s. 
9. Discard the flow-through, and centrifuge for an additional 1 min to remove residual wash    
    buffer 
10. Place the QIAprep column in a clean 1.5 ml microcentrifuge tube. To elute DNA, add 50 µl   
     Buffer EB  (10 mM Tris·Cl, pH 8.5) or water to the center of each QIAprep Spin Column, let    
   stand for 1 min, and centrifuge for 1 min. 
 
2.4.2. TRANSORMATION INTO BL21AI CELLS: 
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 Thaw one vial of BL21-AI cells on ice per transformation.  Add 5–10 ng of DNA, in a volume 
of 1–5 µL to the cells and mix. Incubate the vial on ice for 30 minutes. Heat shock the cells by 
incubating the vial for  30 seconds – 1 minute in the 42°C water bath. Again incubate the vial on 
ice for 15 minutes then add 200 µL LB Broth. shake the vial at 37°C for 1 hour at 225 rpm.  
Centrifuge at 5000 rpm for 5 minutes. remove the supernatant  and add 100 µL of distilled water 
and gently vortex. Plate two different volumes of the transformation reaction onto LB amp plates 
and spread with L-rod. and incubate at 37°C overnight. Select transformants from the plates and 
culture.  
2.4.3. PROTEIN EXPRESSION: 
The positive clone was transformed into BL21 (DE3) pLys cells in LB Agar media, with 
ampicillin (50µg/ul) and chloramphenicol (30µg/µl) and incubated at 37⁰C at 250rpm for 13-
14hrs.Picked 3 colonies from BL21 (DE3) pLysS transformed plate and inoculated into 3ml 
culture media by adding 50µg/ul of ampicillin, incubated at 37⁰C at 250rpm for overnight which 
serve as a pre-inoculum. Took 5% preinoculum into fresh 3ml culture tubes with 50µg/ul of 
ampicillin and grow the bacterial culture till it reaches 0.5-0.6 OD at 600nm.Induce with 1mM 
IPTG and incubated at 37⁰C at 250rpm for 4hrs. Loaded the samples in 12% SDS 
PolyAcrylamideGel with reference to protein ladder .  
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2.4.4. PROTEIN PURIFICATION:  
Added 1% of pre-inoculum into 125ml LB media by adding 50µg/ul of ampicillin and grown the 
bacterial culture till OD reaches 0.5-0.6. Induced with 1mM IPTG and incubated at 37⁰C at 
250rpm. Protein purification was performed by using Ni NTA column, in which cells were lysed 
in lysis buffer(50mMTris-Cl (pH8), 150mM NaCl, 20mM imidazole,1mM BME, 0.5% Triton-
X100,1mM PMSF) followed by sonication and centrifuged at 14.8k rpm for 10 min. Added cell 
lysate to Ni NTA column and collected Flow through followed by adding wash buffer 
(50mMTris-cl (pH8), 150mM NaCl, 20mM imidazole) and collected wash which then followed 
by elution buffer and collected eluted fractions(50mMTris-cl (pH8), 150mM NaCl, 400mM 
imidazole) loaded on in 12% SDS Poly Acryl amide Gel with reference to protein ladder.  
2.4.4. AMYLOID AGGREGATION STUDY: 
Check the amyloid aggregation of above obtained protein by performing congo red dye binding 
assay and Th-T dye binding  assay as mentioned above . 
 
 
 
 
 
 
 
 
 
3 RESULTS AND DISCUSSION: 
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3.1 In vitro formation of BSA  protein amyloid aggregates 
BSA and 50mM NaCl were dissolved in 10mM sodium phosphate buffer pH 7.4 and the 
concentration of  protein was 20 mg/ml. Fibrillization was induced at 65°C for 6 hrs and 10 hrs 
without shaking. After fibrillization some confirmatory assays were performed to confirm the 
formation of amyloid aggregates(Holm et al., 2007, Juarez et al., 2009). 
3.2 BSA  amyloid aggregation detected by Congo-Red dye binding Assay: 
 CR with amyloid shows a little red-shift in its absorption maximum (from around 490 to 540 
nm) and high absorption at 540 nm . The CR+BSA  amyloid aggregates shows red shift from 
490 to 540 nm against only CR and high absorption near 540nm. These results are consistent 
with the presence of cross-beta structures in the BSA  amyloid aggregates. 
 
            
                               Absorption spectra of BSA  fibrillization 
 
3.3 BSA  amyloid aggregation detected by Thioflavin T dye binding Assay: 
Fluorescence endpoint reading of BSA was measured at 450 nm excitation & 485 nm emission 
wavelength. The endpoint reading of BSA  amyloid aggregates at 65°C showed 16.3 fold  
Thioflavin T fluorescence increase . This much fold increase in Th-T fluorescence is an 
indication of amyloid formation. 
22 
 
 
Thioflavin-T fluorescence end point reading at 450nm excitation and 485 nm emission 
Blank (pH 7.4 buffer) BSA amyloid aggregates Fold increase 
155.7 2537.9 16.3 
  
 
3.3.1 Emission and Excitation spectra of BSA  fibrillization: 
 Thioflavin-T binds with amyloid aggregates, and giving rise to excitation maximum at 450 nm 
and enhanced emission at 482nm while for free dye excitation maximum at 385 nm and emission 
maximum at 445 nm. BSA showed excitation maxima λmax at 442 nm and emission maxima 
λmax at 495 nm. This indicated the amyloid nature of the aggregated BSA . 
 
                
                                Emission spectra of BSA fibrillization 
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                                    Excitation spectra of BSA fibrillization 
 
3.4. The inhibitory effect of 3-aminophenol on lysozyme fibrillization: 
Incubation of lysozyme under conditions of low pH and elevated temperature resulted in 
formation of amyloid fibrils. Increased temperature, ionic strength or lysozyme concentration 
significantly shortened the lag time of fibril growth. In the present study, we incubated 10 mg/ml 
lysozyme in 10 mM HCl solution (pH 2.0) at 65 °C in the presence or absence of an 
inhibitor(lysozyme:3-aminophenol 1:4). The growth of amyloid fibrils was monitored and 
characterized by ThT fluorescence and transmission electron microscopy.ThT is a fluorescent 
probe for monitoring the formation and growth of amyloid fibrils. The fluorescence intensity of 
ThT increased significantly when the compound specifically binding to the highly ordered β-
sheet structure of amyloid fibrils . As depicted, an increase in ThT fluorescence emission was 
observed after incubating the control sample . The intensity of ThT fluorescence increased 
gradually as the amyloid formation progressed.  
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                        Emission spectrum  at 0 hrs incubation 
 
           
                     Excitation spectrum at 0 hrs incubation 
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  AFTER 24 HRS INCUBATION: 
           
                                    Emission spectrum 
 
             
                                         Excitation spectrum 
3-aminophenol showed significant inhibitory effect on lysozyme amyloid formation 
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 3.5 The inhibitory effect of 3-aminophenol on BSA fibrillization: 
Various small molecule inhibitors of amyloid fibrillogenesis have been introduced.  3-
aminophenol was studied class of such inhibitors, have been shown to inhibit lysozyme  
amyloid-forming systems. To determine whether that compound affect the process of BSA 
amyloid formation or not. 
Incubation of BSA under conditions of pH 7.4 and elevated temperature resulted in formation of 
amyloid fibrils. Increased temperature, ionic strength or BSA concentration significantly 
shortened the lag time of fibril growth . In the present study, we incubated 10 mg/ml BSA in 
10 mM PBS solution (pH 7.4) at 65 °C in the presence and  absence of an inhibitor. The effective 
molar concentration ratio BSA to 3 aminophenol is 1:4. The growth of amyloid fibrils was 
monitored and characterized by ThT fluorescence. In the case of lysozyme, 3-aminophenol 
prevent the formation of lysozyme fibrillization 
ThT is a fluorescent probe for monitoring the formation and growth of amyloid fibrils. The 
fluorescence intensity of ThT increased significantly when the compound specifically binding to 
the highly ordered β-sheet structure of amyloid fibrils.  ThT fluorescence emission was observed 
after incubating the  sample for 10 hrs.  
ThT fluorescence emission and excitation specta profiles showed similar pattern in the cases of 
with and without inhibitor(3-aminophenol),indication that 3-aminophenol had no effect on BSA 
fibrillization. 
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                                                   Emission spectrum 
                       
                                                  Excitation spectrum 
3.6  The inhibitory effect of GPS-1 on BSA fibrillization: 
Incubation of BSA under conditions of pH 7.4 and at 65oc  temperature  for 10 hrs resulted in 
formation of amyloid fibrils. In the present study, we incubated 10 mg/ml BSA in 10 mM PBS 
solution (pH 7.4) at 65 °C in the presence and absence of an inhibitor. The effective molar 
concentration ratio BSA to GPS-1 is 1:4. The growth of amyloid fibrils was monitored and 
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characterized by ThT fluorescence. ThT fluorescence spectra was observed after incubating the  
sample for 10 hrs.  
ThT fluorescence emission and excitation profiles showed different  pattern in the cases of with 
and without inhibitor unlike 3 aminophenol ,indication that GPS-1 has effect on BSA 
fibrillization. 
                 
                
                    
                                                 Emission spectrum 
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                                              Excitation spectrum 
GPS-1 showed little significant  inhibitory effect on BSA amyloid at  dose 4:1 (inhibitor:BSA). 
So that if we can increase the molar concentration ratio , it may show inhibitory  more effect on 
BSA amyloid fibrillization.  
The molar concentrations has to be taken 1:10 , 1:20 , 1:50 , 1:100 (BSA:GPS-1) .  
1:10  
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                                  Excitation spectrum (BSA:GPS-1=1:10) 
 
 
                  
                              Emission spectrum (BSA:GPS-1=1:20) 
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                                Excitation spectrum (BSA:GPS-1=1:20) 
 
               
                                   Emission spectrum (BSA:GPS-1=1:50) 
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                              Excitation spectrum (BSA:GPS-1=1:50) 
 
BSA:GPS-1=1:10           
           
 
 
 
BSA:GPS-1=1:20 
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BSA:GPS-1=1:50 
 
            
GPS-1 showed more significant  inhibitory effect on BSA amyloid at  dose 50:1 (inhibitor:BSA) 
compare to all other effective molar concentration ratios. 
3.7.  Finding inhibitor for p1510 rnq 1 prion protein: 
After isolation of p1510 1 prion protein by mini-prep , which is transformed in to BL21AI cells. 
Protein expression was performed as mentioned in methods. Protein purification was performed 
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by using Ni NTA column in which cells were lysed in lysis buffer(50mMTris-Cl (pH8), 150mM 
NaCl, 20mM imidazole,1mM BME, 0.5% Triton-X100,1mM PMSF) followed by sonication and 
centrifuged at 14.8k rpm for 10 min. Added cell lysate to Ni NTA column and collected Flow 
through followed by adding wash buffer (50mMTris-cl (pH8), 150mM NaCl, 20mM imidazole) 
and collected wash which then followed by elution buffer and collected eluted 
fractions(50mMTris-cl (pH8), 150mM NaCl, 400mM imidazole) loaded on in 12% SDS Poly 
Acryl amide Gel with reference to protein ladder. 
 
                    
The molecular weight of the obtained protein is 67kDa. Inhibitory assay was performed after 
obtaining of protein. GPS-1 is the inhibitor which shows singnificant inhibitory action on p1510 
rnq1 prion protein aggregates. The molar ratio of protein and GPS-1 is 1:10. mixed with 5µl 
ThT. Fluorescence was measured in a Molecular Devices M5e Spectra Max Multimode 
microplate reader with excitation and emission wavelengths of 450 and 485nm, respectively for 
endpoint reading. Excitation spectrum was measured by scanning the excitation wavelength from 
250 nm to 470 nm and detecting emission at 495 nm. For emission spectrum, excitation 
wavelength is 442nm and scanned emission wavelength from 460nm to 560nm(LeVine, 1993). 
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                        Emission spectrum after 6hrs of incubation 
                
               
                          Excitation spectrum after 6 hrs of incubation 
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                                   Emission spectrum after 10 hrs of incubation 
 
                     
                                  Excitation spectrum after 10 hrs of incubation 
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